Literature DB >> 4862192

Cryptococcus neoformans. II. Phagocytosis by human leukocytes.

G S Bulmer, M D Sans.   

Abstract

Twenty-four per cent of the leukocytes from healthy human subjects phagocytized an encapsulated strain of Cryptococcus neoformans. Phagocytosis was approximately three times more effective with nonencapsulated mutants of C. neoformans. When the mutants reverted to the encapsulated state, the percentages of phagocytosis decreased. These data indicate that cryptococcal polysaccharide inhibits the phagocytosis of C. neoformans by human leukocytes.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4862192      PMCID: PMC276851          DOI: 10.1128/jb.94.5.1480-1483.1967

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  10 in total

1.  Phagocytosis of yeast cells in vitro.

Authors:  C J WANG; J SCHWARZ
Journal:  Am J Pathol       Date:  1959 Jul-Aug       Impact factor: 4.307

2.  Phagocytosis of Cryptococcus neoformans in anemic mice.

Authors:  H H GADEBUSCH
Journal:  J Bacteriol       Date:  1959-08       Impact factor: 3.490

3.  Passive immunization against Cryptococcus neoformans.

Authors:  H H GADEBUSCH
Journal:  Proc Soc Exp Biol Med       Date:  1958-07

4.  The submerged culture of mammalian cells; the spinner culture.

Authors:  W F McLIMANS; E V DAVIS; F L GLOVER; G W RAKE
Journal:  J Immunol       Date:  1957-11       Impact factor: 5.422

5.  The pulmonary lesions in cryptococcosis with special reference to subpleural nodules.

Authors:  R K HAUGEN; R D BAKER
Journal:  Am J Clin Pathol       Date:  1954-12       Impact factor: 2.493

6.  [Isolation and concentration of active leukocytes and thrombocytes by means of polyvinyl-pyrrolidin].

Authors:  H BRAUNSTEINER; F PAKESCH; H VETTER
Journal:  Acta Haematol       Date:  1952-11       Impact factor: 2.195

7.  [Inhibition of leukocyte migration in vitro by a capsular polyoside of Torulopsis (Cryptococcus) neoformans].

Authors:  E DROUHET; G SEGRETAIN
Journal:  Ann Inst Pasteur (Paris)       Date:  1951-12

8.  Passively-acquired immunity in experimental cryptococcosis.

Authors:  D B Louria; T Kaminski
Journal:  Sabouraudia       Date:  1965-06

9.  Further studies on acquired resistance to murine cryptococcosis: enhancing effect of Bordetella pertussis.

Authors:  I Abrahams
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

10.  Cryptococcus neoformans. I. Nonencapsulated mutants.

Authors:  G S Bulmer; M D Sans; C M Gunn
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

  10 in total
  48 in total

Review 1.  A yeast under cover: the capsule of Cryptococcus neoformans.

Authors:  Indrani Bose; Amy J Reese; Jeramia J Ory; Guilhem Janbon; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2003-08

Review 2.  Role of phagocytosis in the virulence of Cryptococcus neoformans.

Authors:  Maurizio Del Poeta
Journal:  Eukaryot Cell       Date:  2004-10

3.  Characterization of a suppressor factor that regulates phagocytosis by macrophages in murine cryptococcosis.

Authors:  R Blackstock; N K Hall; N C Hernandez
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

4.  Expression of capsule-associated genes of Cryptococcus neoformans.

Authors:  Ken Okabayashi; Rui Kano; Shinichi Watanabe; Atsuhiko Hasegawa
Journal:  Mycopathologia       Date:  2005-08       Impact factor: 2.574

5.  Differential localization of complement component 3 within the capsular matrix of Cryptococcus neoformans.

Authors:  Marcellene A Gates; Thomas R Kozel
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

6.  In vitro interactions of immune lymphocytes and Cryptococcus neoformans.

Authors:  P Y Fung; J W Murphy
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

Review 7.  Immunity in cryptococcosis: an overview.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1982-03-19       Impact factor: 2.574

8.  Genetic study of oxygen resistance and melanization in Cryptococcus neoformans.

Authors:  H S Emery; C P Shelburne; J P Bowman; P G Fallon; C A Schulz; E S Jacobson
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Cryptococcus neoformans. 3. Inhibition of phagocytosis.

Authors:  G S Bulmer; M D Sans
Journal:  J Bacteriol       Date:  1968-01       Impact factor: 3.490

10.  Galactoxylomannans of Cryptococcus neoformans.

Authors:  P G James; R Cherniak
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.